» Articles » PMID: 35549873

The Wider Considerations in Closing Chronic Disease Gaps - Focus on Heart Failure and Implementation

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Heart failure (HF) is predominately a chronic disease. There are overlaps in HF and chronic disease research and care. Chronic disease and HF research are conducted with multiple goals. The overarching goal is "optimized patient outcomes at maximum costeffectiveness". However, observations on patients can come with many variables; thus, we see differences in clinical translation. This document discusses an argument for three important gaps common to HF and chronic disease, i.e., screening, self-management, and patient-reported outcomes (PRO), and provides a glance of how it could fit into the evidence tree. Pertinent arguments for a framework for health services and models of care are provided as a prelude to future consensus.

Methodology: 1) A preliminary literature review to identify a taxonomy for cardiovascular research, and 2) a review of the published literature describing the translation of research studies into clinical practice for cardiovascular disorders. A spectrum from observational to large randomized controlled trials to post-marketing studies were identified.

Discussion: A brief discussion on traditional research and differences focusing on screening, mixed methods research concepts, and chronic diseases models of care. Six steps to facilitate this: 1) Research design; 2) Research application (translation) i. routine ii. challenges; 3. Transforming research to translational level; 4. Funding and infrastructure; 5. Clinical Centres of Research Excellence (CCRE) and collaboration; 6. Governance and cost-effectiveness.

Conclusion: Implementation research that aims to link research findings to improved patient outcomes in an efficient and effective way is a neglected area. Skills required to perform implementation research are complex. Ways to maximize translational impacts for chronic disease research to clinical practice are described in a HF context.

Citing Articles

Heart Failure Paradigms in the Developed World - A 'Taproot' Plan (Part 2).

Iyngkaran P, de Courten M Curr Cardiol Rev. 2022; 18(4):e130522204750.

PMID: 35570514 PMC: 9893131. DOI: 10.2174/1573403X18666220513122705.

References
1.
Havranek E, Mujahid M, Barr D, Blair I, Cohen M, Cruz-Flores S . Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2015; 132(9):873-98. DOI: 10.1161/CIR.0000000000000228. View

2.
Smith Jr S . Risk-reduction therapy: the challenge to change. Presented at the 68th scientific sessions of the American Heart Association November 13, 1995 Anaheim, California. Circulation. 1996; 93(12):2205-11. DOI: 10.1161/01.cir.93.12.2205. View

3.
Bennett S, Casey Jr D, Ganiats T, Hlatky M, Konstam M, Pina I . ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical.... J Am Coll Cardiol. 2005; 46(6):1144-78. DOI: 10.1016/j.jacc.2005.07.012. View

4.
Gal D, Thijs B, Glanzel W, Sipido K . A Changing Landscape in Cardiovascular Research Publication Output: Bridging the Translational Gap. J Am Coll Cardiol. 2018; 71(14):1584-1589. DOI: 10.1016/j.jacc.2018.01.073. View

5.
Iyngkaran P, Toukhsati S, Harris M, Connors C, Kangaharan N, Ilton M . Self Managing Heart Failure in Remote Australia - Translating Concepts into Clinical Practice. Curr Cardiol Rev. 2016; 12(4):270-284. PMC: 5304248. DOI: 10.2174/1573403x12666160703183001. View